Ralph P. Insinga

4.3k total citations
50 papers, 3.3k citations indexed

About

Ralph P. Insinga is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Ralph P. Insinga has authored 50 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 21 papers in Oncology and 19 papers in Surgery. Recurrent topics in Ralph P. Insinga's work include Cervical Cancer and HPV Research (27 papers), Genital Health and Disease (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Ralph P. Insinga is often cited by papers focused on Cervical Cancer and HPV Research (27 papers), Genital Health and Disease (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Ralph P. Insinga collaborates with scholars based in United States, United Kingdom and Belgium. Ralph P. Insinga's co-authors include Erik J. Dasbach, Elamin H. Elbasha, Brenda B. Rush, Andrew G. Glass, James M. Pellissier, Robbin Itzler, Evan R. Myers, Patricia Saddier, Alexander Nikas and Kai-Li Liaw and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and American Journal of Obstetrics and Gynecology.

In The Last Decade

Ralph P. Insinga

49 papers receiving 3.1k citations

Peers

Ralph P. Insinga
Cornelia L. Trimble United States
Ciro V. Sumaya United States
Diane D. Davey United States
Lucy A. McNamara United States
Helen Trottier Canada
Ann Moriarty United States
Radha Railkar United States
Kai‐Li Liaw United States
Severin Olesen Larsen Denmark
Julia C. Gage United States
Cornelia L. Trimble United States
Ralph P. Insinga
Citations per year, relative to Ralph P. Insinga Ralph P. Insinga (= 1×) peers Cornelia L. Trimble

Countries citing papers authored by Ralph P. Insinga

Since Specialization
Citations

This map shows the geographic impact of Ralph P. Insinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph P. Insinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph P. Insinga more than expected).

Fields of papers citing papers by Ralph P. Insinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph P. Insinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph P. Insinga. The network helps show where Ralph P. Insinga may publish in the future.

Co-authorship network of co-authors of Ralph P. Insinga

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph P. Insinga. A scholar is included among the top collaborators of Ralph P. Insinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph P. Insinga. Ralph P. Insinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Nan, et al.. (2021). A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung Cancer. PharmacoEconomics - Open. 5(3). 365–383. 12 indexed citations
2.
Loong, Herbert H., Carlos King Ho Wong, Praveen Dhankhar, et al.. (2019). Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong. PharmacoEconomics - Open. 4(2). 235–247. 21 indexed citations
3.
4.
Stafford, Megan, Asha Hareendran, Daisy Ng‐Mak, et al.. (2012). EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs. Health and Quality of Life Outcomes. 10(1). 65–65. 36 indexed citations
5.
Insinga, Ralph P., Gonzalo Pérez, Cosette M. Wheeler, et al.. (2011). Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance. Cancer Epidemiology Biomarkers & Prevention. 20(2). 287–296. 89 indexed citations
6.
Xu, Ruifeng, Ralph P. Insinga, Wendy L. Golden, & Xiaohan Hu. (2010). EuroQol (EQ-5D) health utility scores for patients with migraine. Quality of Life Research. 20(4). 601–608. 44 indexed citations
7.
8.
Singhal, Puneet K., et al.. (2009). Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans. PharmacoEconomics. 27(9). 781–792. 55 indexed citations
9.
Henk, Henry J., Ralph P. Insinga, Puneet K. Singhal, & Theodore Darkow. (2009). Incidence and Costs of Cervical Intraepithelial Neoplasia in a US Commercially Insured Population. Journal of Lower Genital Tract Disease. 14(1). 29–36. 47 indexed citations
10.
Dasbach, Erik J., et al.. (2009). The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.. PubMed. 9(3). 459–66. 31 indexed citations
11.
Elbasha, Elamin H., Erik J. Dasbach, Ralph P. Insinga, Richard M. Haupt, & Eliav Barr. (2009). Age-Based Programs for Vaccination against HPV. Value in Health. 12(5). 697–707. 25 indexed citations
12.
Barr, Eliav, Christine K. Gause, Oliver Bautista, et al.. (2008). Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women. American Journal of Obstetrics and Gynecology. 198(3). 261.e1–261.e11. 25 indexed citations
13.
Ruchlin, Hirsch S. & Ralph P. Insinga. (2008). A Review of Health-Utility Data for Osteoarthritis. PharmacoEconomics. 26(11). 925–935. 27 indexed citations
14.
15.
Insinga, Ralph P., Robbin Itzler, & James M. Pellissier. (2007). Acute/Subacute Herpes Zoster. PharmacoEconomics. 25(2). 155–169. 45 indexed citations
16.
Insinga, Ralph P., Robbin Itzler, James M. Pellissier, Patricia Saddier, & Alexander Nikas. (2005). The incidence of herpes zoster in a United States administrative database. Journal of General Internal Medicine. 20(8). 748–753. 376 indexed citations
17.
Insinga, Ralph P., Andrew G. Glass, & Brenda B. Rush. (2004). The health care costs of cervical human papillomavirus–related disease. American Journal of Obstetrics and Gynecology. 191(1). 114–120. 109 indexed citations
18.
Insinga, Ralph P. & Dennis G. Fryback. (2003). Understanding differences between self-ratings and population ratings for health in the EuroQOL. Quality of Life Research. 12(6). 611–619. 48 indexed citations
19.
Insinga, Ralph P., Erik J. Dasbach, & Evan R. Myers. (2003). The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States. Clinical Infectious Diseases. 36(11). 1397–1403. 180 indexed citations
20.
Insinga, Ralph P., Ronald H. Laessig, & Gary Hoffman. (2002). Newborn screening with tandem mass spectrometry: Examining its cost-effectiveness in the Wisconsin Newborn Screening Panel. The Journal of Pediatrics. 141(4). 524–531. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelia L. Trimble Breakdown of academic impact, for papers by Ciro V. Sumaya Breakdown of academic impact, for papers by Diane D. Davey Breakdown of academic impact, for papers by Lucy A. McNamara Breakdown of academic impact, for papers by Helen Trottier Breakdown of academic impact, for papers by Ann Moriarty Breakdown of academic impact, for papers by Radha Railkar Breakdown of academic impact, for papers by Kai‐Li Liaw Breakdown of academic impact, for papers by Severin Olesen Larsen Breakdown of academic impact, for papers by Julia C. Gage
Rankless by CCL
2026